CryoLife, Inc. (CRY) Reaches $26.33 After 8.00% Up Move; Tekla Capital Management Boosted By $362,632 Its Quotient Limited (QTNT) Holding

May 18, 2018 - By Sherry Myers

Quotient Limited (NASDAQ:QTNT) Logo

The stock of CryoLife, Inc. (NYSE:CRY) is a huge mover today! The stock increased 3.64% or $0.93 during the last trading session, reaching $26.33. About 223,353 shares traded or 72.96% up from the average. CryoLife, Inc. (NYSE:CRY) has risen 19.34% since May 18, 2017 and is uptrending. It has outperformed by 7.79% the S&P500.The move comes after 8 months positive chart setup for the $964.35 million company. It was reported on May, 18 by Barchart.com. We have $28.44 PT which if reached, will make NYSE:CRY worth $77.15 million more.

Tekla Capital Management Llc increased Quotient Limited (QTNT) stake by 76.27% reported in 2017Q4 SEC filing. Tekla Capital Management Llc acquired 90,658 shares as Quotient Limited (QTNT)’s stock declined 8.51%. The Tekla Capital Management Llc holds 209,519 shares with $1.04M value, up from 118,861 last quarter. Quotient Limited now has $245.26M valuation. The stock increased 14.71% or $0.69 during the last trading session, reaching $5.38. About 2.26M shares traded or 630.82% up from the average. Quotient Limited (NASDAQ:QTNT) has declined 24.44% since May 18, 2017 and is downtrending. It has underperformed by 35.99% the S&P500.

Among 3 analysts covering Quotient (NASDAQ:QTNT), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quotient had 6 analyst reports since August 11, 2015 according to SRatingsIntel. The rating was upgraded by Zacks to “Hold” on Friday, August 14. On Wednesday, November 1 the stock rating was maintained by Jefferies with “Buy”. The company was maintained on Wednesday, November 4 by UBS. The rating was initiated by Jefferies with “Buy” on Tuesday, August 11. The rating was initiated by BTIG Research with “Buy” on Thursday, August 31. BTIG Research maintained Quotient Limited (NASDAQ:QTNT) on Tuesday, February 6 with “Buy” rating.

Tekla Capital Management Llc decreased Mckesson Corporation (NYSE:MCK) stake by 18,850 shares to 123,950 valued at $19.33 million in 2017Q4. It also reduced Johnson & Johnson (NYSE:JNJ) stake by 62,800 shares and now owns 736,132 shares. Neurocrine Biosciences Inc. (NASDAQ:NBIX) was reduced too.

More notable recent Quotient Limited (NASDAQ:QTNT) news were published by: Streetinsider.com which released: “Pre-Open Movers 05/18: (QTNT) (AFSI) (CERN) Higher; (AGRX) (ARQL) (CPB) Lower (more…)” on May 18, 2018, also Streetinsider.com with their article: “After-Hours Stock Movers 05/17: (QTNT) (VJET) (AFSI) Higher; (ARQL) (JWN) (AMAT) Lower (more…)” published on May 17, 2018, Streetinsider.com published: “Quotient (QTNT) Commences EU Blood Grouping Field Trial” on May 17, 2018. More interesting news about Quotient Limited (NASDAQ:QTNT) were released by: Nasdaq.com and their article: “Quotient Limited Reports Commencement of EU Blood Grouping Field Trial” published on May 17, 2018 as well as Globenewswire.com‘s news article titled: “Quotient Limited to Report Fourth Quarter and Fiscal Full Year 2018 Financial Results and Host Conference Call” with publication date: May 15, 2018.

Investors sentiment increased to 1.93 in 2017 Q4. Its up 0.51, from 1.42 in 2017Q3. It improved, as 5 investors sold QTNT shares while 10 reduced holdings. 7 funds opened positions while 22 raised stakes. 30.23 million shares or 41.49% more from 21.37 million shares in 2017Q3 were reported. Cormorant Asset Mgmt Lc reported 4.49 million shares. Voya Inv Mgmt Ltd Com invested in 12,325 shares or 0% of the stock. 4,074 were accumulated by Parallax Volatility Advisers Lp. Parametric Portfolio Associate Llc holds 0% or 10,194 shares. Highbridge Cap Management Lc invested in 2.28 million shares or 0.2% of the stock. State Street Corporation reported 378,984 shares. Moreover, Hudson Bay Capital Management Limited Partnership has 0.05% invested in Quotient Limited (NASDAQ:QTNT). Polar Cap Llp invested in 0.26% or 6.80 million shares. Tiaa Cref Ltd Limited Liability Company holds 0% or 75,241 shares in its portfolio. Bancorporation Of Mellon Corp invested in 56,936 shares or 0% of the stock. Knott David M stated it has 0.19% of its portfolio in Quotient Limited (NASDAQ:QTNT). Geode Capital Mgmt reported 75,232 shares or 0% of all its holdings. Vanguard Group Inc Inc invested in 73,012 shares. 108,676 were reported by Morgan Stanley. 2.15M were reported by Ameriprise Fincl.

Since February 21, 2018, it had 1 buying transaction, and 0 insider sales for $51,348 activity. von Prondzynski Heino bought $51,348 worth of stock or 12,000 shares.

Since December 15, 2017, it had 0 buys, and 13 sales for $1.38 million activity. $44,000 worth of CryoLife, Inc. (NYSE:CRY) shares were sold by RONALD C ELKINS. McCall Ronald D sold 5,000 shares worth $105,448. $113,698 worth of CryoLife, Inc. (NYSE:CRY) was sold by Davis John E. 4,000 shares were sold by Horton Amy, worth $103,764. Shares for $256,999 were sold by LEE DAVID ASHLEY on Wednesday, May 9.

Analysts await CryoLife, Inc. (NYSE:CRY) to report earnings on July, 23. They expect $-0.01 EPS, down 108.33% or $0.13 from last year’s $0.12 per share. After $0.02 actual EPS reported by CryoLife, Inc. for the previous quarter, Wall Street now forecasts -150.00% negative EPS growth.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $964.35 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It has a 246.03 P/E ratio. The firm operates in two divisions, Medical Devices and Preservation Services.

More news for CryoLife, Inc. (NYSE:CRY) were recently published by: Seekingalpha.com, which released: “CryoLife’s (CRY) CEO Pat Mackin on Q1 2018 Results – Earnings Call Transcript” on May 06, 2018. Streetinsider.com‘s article titled: “CryoLife (CRY) Reports In-Line Q1 EPS” and published on May 02, 2018 is yet another important article.

Among 4 analysts covering Cryolife (NYSE:CRY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cryolife had 12 analyst reports since April 13, 2016 according to SRatingsIntel. Northland Capital maintained CryoLife, Inc. (NYSE:CRY) on Monday, May 1 with “Buy” rating. On Sunday, October 8 the stock rating was maintained by Canaccord Genuity with “Buy”. Canaccord Genuity maintained CryoLife, Inc. (NYSE:CRY) rating on Tuesday, January 2. Canaccord Genuity has “Buy” rating and $25.0 target. The stock of CryoLife, Inc. (NYSE:CRY) earned “Buy” rating by Lake Street on Wednesday, June 15. Ladenburg Thalmann upgraded the shares of CRY in report on Friday, February 17 to “Buy” rating. The stock of CryoLife, Inc. (NYSE:CRY) earned “Buy” rating by Canaccord Genuity on Wednesday, April 13. On Tuesday, October 31 the stock rating was maintained by Canaccord Genuity with “Buy”. Northland Capital maintained CryoLife, Inc. (NYSE:CRY) rating on Tuesday, July 25. Northland Capital has “Buy” rating and $23.5000 target. As per Thursday, March 8, the company rating was maintained by Canaccord Genuity. The rating was initiated by Northland Capital with “Outperform” on Monday, January 9.

CryoLife, Inc. (NYSE:CRY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: